期刊名称：ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Environmental Toxicology and Pharmacology publishes the results of studies concerning toxic and pharmacological effects of (human and veterinary) drugs and of environmental contaminants in animals and man.
Areas of special interest are: molecular mechanisms of toxicity, biotransformation and toxicokinetics (including toxicokinetic modelling), molecular, biochemical and physiological mechanisms explaining differences in sensitivity between species and individuals, the characterisation of pathophysiological models and mechanisms involved in the development of effects and the identification of biological markers that can be used to study exposure and effects in man and animals.
In addition to full length papers, short communications, full-length reviews and mini-reviews, Environmental Toxicology and Pharmacology will publish in depth assessments of special problem areas. The latter publications may exceed the length of a full length paper three to fourfold. A basic requirement is that the assessments are made under the auspices of international groups of leading experts in the fields concerned. The information examined may either consist of data that were already published, or of new data that were obtained within the framework of collaborative research programmes. Provision is also made for the acceptance of minireviews on (classes of) compounds, toxicities or mechanisms, debating recent advances in rapidly developing fields that fall within the scope of the journal.
The table of contents for this journal is now available pre-publication, via e-mail, as part of the free ContentsDirect service from Elsevier Science. Please send an e-mail message to cdhelp@elsevier.co.uk for further information about this service.
Audience
Pharmacologists, toxicologists, environmental scientists
Abstracting / Indexing
- BIOSIS
- Chemical Abstracts
- Current Contents/Life Sciences
- EMBASE
- Elsevier BIOBASE
- Environmental Mutagene Information Center
- Index Medicus
Instructions to Authors
Authors should consult the extensive 'Instructions to authors' (see Vol. 1, No. 1, p. vii) when preparing a manuscript for submission.
The original and 3 copies. complete with 4 sets of figures and tables should be sent to the Editorial Office responsible for your region:
The Americas: R.F. Seegal, Wadsworth Center, New York State Department of Health and School of Public Health, University of Albany, Albany, NY 12201-0509, USA (Fax: +1-518.4861505: E-mail: seegal@wadsworth.org).
Rest of World: The Editorial Office, Environmental Toxicology and Pharmacology, LACDR - Division of Molecular Toxicology, Department of Pharmacochemistry, Vrije Universiteit, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands (Fax: +31 20 444 76 10); E-mail: ETAP@chem.vu.nl.
Authors must include the following contact details on the title page of their submitted manuscripts: name: full postal address; Fax; Tel; e-mail. The preferred medium of final submission to the accepting editor is on disk with the accompanying reviewed and revised manuscript (see 'Electronic manuscripts' below). Manuscripts submitted by facsimile transmission will not be considered. Manuscripts should be typewritten or printed with double spacing (at least 6 mm between lines) and with wide margins (not more than 26 lines per page). The possibility that accepted manuscripts will be processed by electronic scanning makes it essential that the typing/printing be of the highest quality. A standard, at least 12-point (0.0138 inch), type face, neither distorted nor reduced or enlarged, is to be used. Manuscripts printed with low-quality printers will be returned for retyping with an acceptable type face. Manuscripts should be written in English: only light correction of English style and language will be carried out during production. Should more extensive changes be necessary, the manuscripts will be returned to the authors for retyping. Submission of a paper in clear, grammatical English will, therefore, shorten publication time considerably. Authors in Japan please note: Upon request, Elsevier Science Japan will provide authors with a list of people who can check and improve the English of their paper (before submission). Please contact our Tokyo office: Elsevier Science Japan, 1-9-15 Higashi-Azabu, Minato-ku, Tokyo 106; Tel. (03)-556l-5032: Fax (03)-5561-5045.
1. Electronic manuscripts
Electronic manuscripts have the advantage that there is no need for the rekeying of text, thereby avoiding the possibility of introducing errors and resulting in reliable and fast delivery of proofs. The preferred storage medium is a 5¨ù or 3¨ö inch disk in MS-DOS format, although other systems are welcome, e.g., NEC and Macintosh (in this case, save your file in the usual manner, do not use the option 'save in MS-DOS format'). Please do not split the article into separate files (title page as one file, text as another, etc.). Ensure that the letter 'I' and digit '1' (also letter 'O' and digit '0') have been used properly, and structure your article (tabs, indents, etc.) consistently. Characters not available on your wordprocessor (Greek letters, mathematical symbols, etc.) should not be left open but indicated by a unique code (e.g., gralpha, @, #, etc., for the Greek letter ). Such codes should be used consistently throughout the entire text. Please make a list of such codes and provide a key. Do not allow your wordprocessor to introduce word splits and do not use a 'justified' layout. Please adhere strictly to the general instructions on style/arrangement and, in particular, the reference style of the journal. It is very important that you save your file in the wordprocessor format. If your wordprocessor features the option to save files 'in flat ASCII', please do not use it. Format your disk correctly and ensure that only the relevant file (one complete article only) is on the disk. Also, specify the type of computer and wordprocessing package used, and label the disk with your name and the name of the file on the disk. After final acceptance, your disk plus one, final, printed and exactly matching version (as a printout) should be submitted together to the accepting editor. It is important that the file on disk and the printout are identical. Both will then be forwarded by the editor to Elsevier. Further information may be obtained from the publisher.
2. Full length manuscripts
(a) The manuscript should be arranged as follows. First page: title (not exceeding 85 characters including spaces between words); surname(s) of author(s), preceded by one name spelled out in full; name and address of the establishment where the work was done; name, full postal address, telephone and telefax numbers of author to whom proofs and other correspondence should be sent. Next page (2): abstract and keywords (indexing terms: normally 3-6 items); Pages 3 to end: 1. Introduction; 2. Materials and methods; 3. Results; 4. Discussion; Acknowledgements; References; figure legends and figures; tables. Both sections and their subdivisions should be numbered (2.1., 2.2., 2.3. etc).
(b) Abstract and keywords: and abstract not exceeding 150 words and stating what was done, what was found, and what was concluded should be typed on a separate sheet. Below the abstract, type 3-6 keywords or short phrases suitable for indexing. These terms will be printed at the end of the abstract. If possible. keywords should be selected from Index Medicus or Excerpta Medica Index. First category key-words (e.g. Hyperphagia; G-Strophantidin; Fiber shortening) will all be listed and cross-indexed. Second category keywords (e.g. Rat, Cold, Metabolite) will only be listed under the index entry for the first category keywords. If the editors feel that keywords should be adjusted to the standards of the journal this will be done without consultation of the author(s).
(c) Standard nomenclature should be used throughout. Avoid unnecessary abbreviations and symbols (see extensive 'Instructions to authors' (Vol. 1, No. 1, p. vii). Words at the end of a line should not be divided. Use of hyphens, capital letters. numbers written or spelled out (e.g. 8 or eight) should be consistent throughout the manuscript.
(d) Legends of illustrations and footnotes should be typed on separate sheets, lines double spaced. Footnotes, to be numbered consecutively in superscript throughout the text, should be used as little as possible.
(e) Drugs: generic names should be used. Trade names may be mentioned in parentheses the first time the name of the drug appears in the text. The form of the drug used should be indicated.
3. Short communications should be prepared as described under 2, except for the following:
(a) The average length of a short communication should not exceed 4 pages in print (approx. 2000-2300 words, including abstract, captions and references). A maximum of 2 illustrations (figures or tables) is allowed.
(b) An abstract of not more that 100 words should be provided and 3-6 keywords should be listed immediately below the abstract.
4. Reviews
The organization and subdivision of review articles can be arranged at the author's discretion. Tables, figures and references are to be arranged in the same way as research articles in the journal. Please contact the Editor before submitting an article for this section.
5. Mini-reviews
(a) The total length of a mini-review should be about 30 double-spaced typewritten pages, including references, tables and figures.
(b) A brief introduction to the subjects, comprising not more than 500 words, in which reference is made to recent key articles or reviews on the topic should be given.
(c) Conclusions should be summarized in 500-1000 words at the end of this article. They should be preferentially outlined in a flow diagram or a graph.
(d) A maximum of 40 references may be used.
6. Assessments
The format of an assessment will be decided upon in consultation with the editors.
7. Letters to the editors
The total length of a letter should not exceed one page.
8. References
References in the text to literature cited should be given by the name of the author(s), followed by the year of publication in parentheses, e.g.: Seegal and Sham (1992) or (Safe, 1986; Pluim et al., 1993; Ahlborg et al., 1994, 1995a,b).For three or more authors the name of the first author followed by et al. should be used. Journal names should be abbreviated according to the List of Serial Title Word Abbreviations (available from the International Serials Data System, 20 Rue Bachaumont, 75002 Paris, France; ISBN 2-904938-02-8). References should be listed alphabetically. Citations of the literature in the list of references should include the full title of the article referred to. Personal communications and unpublished data should not appear in the list of references.
Sample references:
Periodicals:
Buijs, J., Egberts, M.E.W.C., Nijkamp. F.P., 1995. Toxocara canis-induced airway eosinophilia and tracheal hyporeactivity in guinea pigs and mice, Eur. J. Pharmacol. Environ. Toxicol. Pharmacol. Sect. 293, 207.
Books:
Kimbrough, R.D., Grandjean, P., 1989. Occupational exposure. In: Kimbrough R.D., Jensen A.A. (Eds.), Halogenated Biphenyls, Terphenyls, Naphthalenes. Dibenzodioxins and Related Products. Elsevier, Amsterdam, p. 485. Vernet, J.-P., 1993, Environmental Contamination, Elsevier, Amsterdam.
9. IllustratIons, graphs and tables (see 'Instructions to authors', Vol. 1, No. 1, p. vii)
(a) Either the original drawings plus 3 good photographs, 4 good photographs of the drawings (on glossy paper and unmounted) or 4 high-quality computer printouts should be submitted. lllustrations may be submitted in electronic format as well, but must always be accompanied by reproducible paper printouts. Photocopies may not be used. The photographs should be of adequate definition and contrast. The number of illustrations should be limited to the essential.
(b) It is important to allow for reduction to fit a single column, 8.4 cm wide, or at most a double column, maximally 17.6 cm wide. Illustrations, especially photomicrographs, should be submitted in their final size (single or double column). When possible, all key symbols should be explained in the figures. The following symbols can be typeset and explained (as well as all lettering) in the legends: All letters and numerals appearing in a particular illustration should be of the same size (approximately 1.4-2 mm height when reduced to 8.4 cm width).
(c) Graphs should be prepared so that the dark, cross-hatched background is eliminated, the faint portions of the graphs intensified, and a sharp print obtained. This process may be avoided by using blue-ruled instead of black-ruled recording paper for the originals.
(d) Drawings of complicated chemical structures should be prepared in the same way as graphs.
(e) A calibration bar should be drawn on the micrographs instead of giving a magnification rate in the figure legend.
(d) All illustrations should be referred to as figures and numbered in Arabic numerals (Fig. 1, 2 etc.).
(g) Legends to figures should make these comprehensible without reference to the text.
(h) Tables should be numbered separately in Arabic numerals (Table 1, 2 etc.).
(i) Colour reproduction of illustrations is available at cost. Original high-quality illustrations (preferably slides) should be well protected against possible damage during shipment. Detailed information regarding the use of colour may be obtained from the publisher, at the time of submission of the manuscript to the editors.
10. Proofs
One set of galley proofs will be sent to the editor named on the title page (see 2.) Proofs will usually be set on lower quality paper. Only printer's errors may be corrected: no changes in, or additions to, the edited manuscript will be allowed. Proofs should be returned within 48 hours to Elsevier Science Ireland Ltd., Elsevier House, Brookvale Plaza, East Park, Shannon, Co. Clare, Ireland, preferably by Fax (+353 61 109107). If this period is exceeded no reminders will be sent, the proof will be assumed to be error-free and printed without the author's corrections.
11. Page charges and reprints
There will be no page charge. 25 free reprints are provided to the corresponding author of each article. Authors will receive a reprint order form with the acknowledgement of receipt and the copyright transfer form from the publisher: this order from should be mailed to the publisher by return post. Reprints ordered after the journal has been printed will cost considerably more than those ordered immediately.
12. Publication information
Environmental Toxicology and Pharmacolog (ISSN 1382-6689). For 2001 volumes 11-12 are scheduled for publication.
Subscription prices are available upon request form the publisher. Subscriptions are accepted on a prepaid basis only and are entered on a calendar year basis. lssues are sent by surface mail except to the following countries where air delivery via SAL mail is ensured: Argentina, Australia, Brazil, Canada, Hong Kong, India, Israel. Japan. Malaysia, Mexico, New Zealand, Pakistan, PR China, Singapore. South Africa. South Korea. Taiwan, Thailand, USA. For all other countries airmail rates are available upon request.
Claims for missing issues must be made within six months of our publication (mailing) date.
Orders, claims and product enquiries: please contact the Customer Support Department at the Regional Sales Office nearest you:
Orlando: Customer Service Department, 6277 Sea Harbor Drive Orlando, FL 32887-4800, USA; Tel: +1 877 839 7126 (Toll-free number) for US Customers, Tel: +1 407 345 4020 for Customers outside US, Fax: +1 407 363 1354, e-mail: usjcs@elsevier.com
Amsterdam: Elsevier Science, PO Box 211, 1000 AE Amsterdam, The Netherlands; phone: (+31) 20 4853757: fax: (+31) 20 4853432: e-mail: nlinfof@elsevier.nl
Tokyo: Elsevier Science, 9-15 Higashi-Azabu 1-chome, Minato-ku, Tokyo 106, Japan: phone: (+81) (3) 5561 5033: fax: (+81) (3) 5561 5047: e-mail: info@elsevier.co.jp
Singapore: Elsevier Science, No. 1 Temasek Avenue, # 17-01 Millenia Tower, Singapore 039192; phone: (+65) 434 3727; fax: (+65) 337 2230: e-mail: asiainfo@elsevier.com.sg
Rio de Janeiro: Elsevier Science, Rua Sete de Setembro 111/16 Andar, 20050-002 Centro, Rio de Janeiro-RJ, Brazil; phone: (+55) (21) 509 5340; fax: (+55) (21) 507 1991; e-mail: elsevier@camputcom.br [Note (Latin America): for orders, claims and help desk information, please contact the Regional Sales Office in New York as listed above.
Author enquiries:
Authors can keep a track of the progress of their accepted article on the Internet on our Author Gateway (go to http://authors.elsevier.com/ )
For specific enquiries on the preparation of electronic artwork, consult http://www.elsevier.com/locate/authorartwork
Contact details for questions arising after acceptance of an article, especially those relating to proofs, are provided when an article is accepted for publication.
12. Advertising information
Advertising orders and enquiries may be sent to:
International: Elsevier Science, Advertising Department, The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, UK. Tel.: (+44) (0) 1865 843565: Fax: (+44) (0) 1865 843976.
U.S.A. and Canada: Elsevier Science Inc., Mr. Tino DeCarlo, 360 Park Avenue South, New York, NY 10010-1710 , USA; Tel: + 1(212) 633 3815; Fax: + 1 (212) 633 3820.
Japan: Elsevier Science Japan, Marketing Services, 1-9-15 Higashi-Azabu, Minato-ku, Tokyo 106, Japan. Tel.: (+81) 3-5561-5033: Fax: (+81) 3-5561-5047.
Editorial Board
Editors:
N.P.E. Vermeulen, Dept. of Pharmacochemistry, Vrije Universiteit, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands. Tel: +31 (0)20 444 7590, Fax: +31 (0)20 444 7610, Email: etap@chem.vu.nl
R.F. Seegal, State of New York University, Department of Health, Wadsworth Center, P.O. Box 509, Albany, NY 12201, USA; Tel: (518)473-4378, Fax: (518)486-1505, Email: seegal@wadsworth.org
Founding Editor:
J.H. Koeman, Emeritus Professor of Toxicology, Thijsselaan 5, 6705 AK Wageningen, The Netherlands; Email: jh.koeman@ZONNET.nl
Editorial Board: P. Beaune, Paris, France
R.P. Bos, Nijmegen, The Netherlands
J. Caldwell, London, UK
M.D. Coleman, Birmingham, UK
P.M. Dansette, Paris, France
M.S. Denison, Davis, CA, USA
J. Doehmer, M¨¹nchen, Germany
P. Eriksson, Uppsala, Sweden
J. Fink-Gremmels, Utrecht, The Netherlands
F. Fonnum, Kjeller, Norway
J.P. Giesy, East Lansing, MI, USA
H.R. Glatt, Potsdam-Rehbr¨¹cke, Germany
M. Gupta, College Station, TX, USA
N. Imura, Tokyo, Japan
H.R. Lam, Soborg, Denmark
T.W. La Point, Pendleton, SC, USA
D. Lawrence, Albany, NY, USA
F.P. Nijkamp, Utrecht, The Netherlands
P.M. O'Byrne, Hamilton, Ont., Canada
I. Pessah, Davis, CA, USA
I.M.C.M. Rietjens, Wageningen, The Netherlands
R.T. Riley, Athens, GA, USA
S.H. Safe, College Station, TX, USA
S. Schantz, Urbana-Champaign, IL, USA
R.P. Sharma, Athens, GA, USA
H. Thomas, Wilmslow, UK
J. Tuomisto, Kuopio, Finland
N.J. van Sittert, Amsterdam, The Netherlands
L. Vittozzi, Rome, Italy
G. Winneke, Dusseldorf, Germany
C.R. Wolf, Dundee, UK
H. Yamasaki, Nishinomiya, Japan
|
刊名字顺( Alphabetical List of Journals):
返回页首 